New York, 29th March 2023: Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to Increased Resilience – Bikash Chatterjee, CEO of Pharmatech Associates [a USP company] forewarns that CDMO supply chains are potentially the biggest single risk to product resilien.
In line with the U.S. Pharmacopeia (USP) initiative to support and guide industry adoption of pharmaceutical continuous manufacturing (PCM), Pharmatech Associates has reached an agreement with Integra
/PRNewswire/ The U.S. Pharmacopeia (USP) today announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its.